help button home button Am J Pathol International Conference on Pathology of Chest Diseases
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
A more recent version of this article appeared on June 1, 2007

Published online before print April 19, 2007
This Article
Right arrow Full Text (Rapid PDF)
Right arrow All Versions of this Article:
ajpath.2007.060709v1
170/6/2135    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chia, J.
Right arrow Articles by Pouliot, N.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Chia, J.
Right arrow Articles by Pouliot, N.
Copyright © 2007 American Society for Investigative Pathology
American Journal of Pathology, doi:10.2353/ajpath.2007.060709

Accepted for publication March 9, 2007.

Article

Evidence for a Role of Tumor-Derived Laminin-511 in the Metastatic Progression of Breast Cancer

Jenny Chia*, Nicole Kusuma*, Robin Anderson*{dagger}, Belinda Parker*{ddagger}, Bradley Bidwell*{ddagger}, Laura Zamurs{sect}, Edouard Nice{sect}, and Normand Pouliot*{dagger}@

From the Peter MacCallum Cancer Centre,* Melbourne; the Departments of Pathology{dagger} and Biochemistry,{ddagger} University of Melbourne, Victoria; and the Ludwig Institute for Cancer Research,{sect} Royal Melbourne Hospital, Parkville, Australia

@ To whom correspondence should be addressed. E-mail: normand.pouliot{at}petermac.org.


  Abstract

Most studies investigating laminins (LMs) in breast cancer have focused on LM-111 or LM-332. Little is known, however, about the expression and function of {alpha}5 chain-containing LM-511/521 during metastatic progression. Expression of LM-511/521 subunits was examined in genetically related breast tumor lines and corresponding primary tumors and metastases in a syngeneic mouse model using real-time quantitative polymerase chain reaction, in situ hybridization, and immunohistochemistry. The results from our investigation indicate that LM-511 rather than LM-111, -332, or -521 correlates with metastatic potential in mouse mammary tumors. LM-511 was a potent adhesive substrate for both murine and human breast carcinoma cells and promoted strong haptotactic responses in metastatic lines. Haptotaxis was mediated by {alpha}3 integrin in both MCF-7 and MDA-MB-231 cells and was strongly inhibited by blocking antibodies against this integrin subunit. However, whereas nonmetastatic MCF-7 cells migrated toward LM-511 primarily via {alpha}3{beta}1 integrin, results from antibody perturbation experiments and flow cytometry analysis suggest that this response is mediated by an as yet unidentified {alpha}3{beta} integrin heterodimer (other than {alpha}3{beta}1) in MDA-MB-231 cells. These results are consistent with earlier reports implicating {alpha}3 integrins in breast cancer progression and support the role of LM-511 as a functional substrate regulating breast cancer metastasis.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2007 by the American Society for Investigative Pathology.